ArticleBMJ oncology2026

CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer.

Sepideh Gholami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.